The purpose of this study is to learn more about a drug called Benralizumab and whether it can be used to safely treat eosinophilic Eosinophilic gastritis and gastroenteritis (EG/EGE).
At each visit you will have your vital signs taken, blood drawn, and urine collected. You will be asked to fill out questionnaires about your quality of life and symptoms and you will receive a drug injection (Benralizumab). You will have up to 4 endoscopies throughout the study.
Information provided upon request, You will not be charged for the study drug, tests, and examinations that are a part of this study. Results of the trial will be available to you.
Clinical or Medical
Stomach, Digestion and Gut Health
Eating, Nutrition, and Metabolism